The South Korean units of McDonald's, Burger King, and KFC are facing growing skepticism over finding new owners for their franchises here, due to increased difficulties in fundraising and a growing preference among domestic consumers for healthier foods.
According to a food and beverage franchise buyout expert, the pool of buyers who can afford higher prices has become smaller because interest rate hikes have worsened the condition of the acquisition financing market.
He added that the chains' valuations will also be impacted by the concurrent sales attempts.
To avoid harsher market conditions next year, Korean fast-food franchise owners must sell their businesses this year.
Fast food restaurants face significant risks from rising labor and ingredient expenses because it is challenging to raise prices to cover these costs.
The snowballing losses in the fried chicken and hamburger business cost KFC's Korean operator KG Group, which led to a capital impairment in 2020.
KG Group is reportedly desperate to sell the KFC franchise for about 100 billion won, to secure enough cash to buy SsangYong Motor.
Following a failed attempt in 2016, McDonald's US headquarters launched another attempt to sell its Korean business.
However, prospective buyers objected to the conditions of the deal.
Operating losses for McDonald's Korea amounted to 44 billion won in 2019, 48,3 billion won in 2020, and 27.7 billion won in 2021.
The operator of Burger King's Korean location, Affinity Equity Partners, is thought to be more in need of a quick sale because it is a PEF and is required to quickly sell its portfolio companies to disperse profits to its investors.
The Hong Kong-based PEF has been attempting to sell the Burger King's Korean unit in 2016 and its Japanese counterpart for a combined 1 trillion won since late last year.
Insiders in the M&A market, however, expressed doubt about the hamburger business being purchased by a PEF and noted that it will be challenging to increase its valuation until divestiture.


Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
AstraZeneca’s LATIFY Phase III Trial of Ceralasertib Misses Primary Endpoint in Lung Cancer Study
California Jury Awards $40 Million in Johnson & Johnson Talc Cancer Lawsuit
South Africa Eyes ECB Repo Lines as Inflation Eases and Rate Cuts Loom
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
China to Add Eli Lilly’s Mounjaro to National Health Insurance in 2025
Oil Prices Slide on US-Iran Talks, Dollar Strength and Profit-Taking Pressure
TrumpRx Website Launches to Offer Discounted Prescription Drugs for Cash-Paying Americans
Viking Therapeutics Sees Growing Strategic Interest in $150 Billion Weight-Loss Drug Market
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Fed Governor Lisa Cook Warns Inflation Risks Remain as Rates Stay Steady
Dollar Near Two-Week High as Stock Rout, AI Concerns and Global Events Drive Market Volatility
Gold Prices Slide Below $5,000 as Strong Dollar and Central Bank Outlook Weigh on Metals
Russian Stocks End Mixed as MOEX Index Closes Flat Amid Commodity Strength 



